Home » Topics » Regulatory » Patents

Patents
RSS

Bayer Pharma patents Wnt signaling pathway inhibitors

Sep. 5, 2016

Glucox Biotech describes novel NADPH oxidase 4 inhibitors

Sep. 5, 2016

Incyte announces PI3Kgamma inhibitors

Sep. 2, 2016

Merck & Co. develops retinoid RORgammaT antagonists

Sep. 2, 2016

Enanta Pharmaceuticals describes FXR agonists

Sep. 2, 2016

Genentech and Roche disclose TRPA1 antagonists

Sep. 2, 2016

Shanghai De Novo Pharmatech patents IDO1 and/or TOD2 inhibitors

Sep. 2, 2016

Daewoong Pharmaceutical announces Nav1.7 sodium channel blockers

Sep. 1, 2016

PsychoGenics and Sunovion Pharmaceuticals develop antidepressants

Sep. 1, 2016

Glenmark Pharmaceuticals discloses ADH5 inhibitors

Sep. 1, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...